Product Detail
Product NameIL-17C Antibody HRP Conjugated
Host SpeciesRabbit
ClonalityPolyclonal
IsotypeIgG
PurificationPurified by Protein A.
ApplicationsWB IHC-P IHC-F
Species ReactivityHu Ms Rt
Immunogen DescKLH conjugated synthetic peptide aa 90-130 197 derived from human IL-17C
Target NameIL-17C
ConjugateHRP
Excitation EmissionN A
Other NamesCX2; IL-17C; Interleukin-17C; Cytokine CX2; IL17C; UNQ561 PRO1122
Accession NoSwiss-Prot#Q9P0M4
NCBI Gene ID27189
Uniprot
Q9P0M4
Gene ID
27189;
Concentration1mg ml
Formulation0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
StorageShipped at 4˚C. Store at -20˚C for one year. Avoid repeated freeze/thaw cycles.
Application Details
WB=1:500-2000 IHC-P=1:50-200 IHC-F=1:50-200
Cytokine that plays a crucial role in innate immunity of the epithelium, including to intestinal bacterial pathogens, in an autocrine manner. Stimulates the production of antibacterial peptides and proinflammatory molecules for host defense by signaling through the NF-kappa-B and MAPK pathways. Acts synergically with IL22 in inducing the expression of antibacterial peptides, including S100A8, S100A9, REG3A and REG3G. Synergy is also observed with TNF and IL1B in inducing DEFB2 from keratinocytes. Depending on the type of insult, may have both protective and pathogenic properties, either by maintaining epithelial homeostasis after an inflammatory challenge or by promoting inflammatory phenotype. Enhanced IL17C IL17RE signaling may also lead to greater susceptibility to autoimmune diseases.
If you have published an article using product C04220H, please notify us so that we can cite your literature.
15 business days.
